Concord Drugs Ltd.
| BSE: 538965 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE858L01010 |
| BSE 00:00 | 01 Jul | 25.90 |
-2.35 (-8.32%) |
OPEN
25.60 |
HIGH
28.25 |
LOW
25.60 |
| NSE 05:30 | 01 Jan | Concord Drugs Ltd |
| OPEN | 25.60 |
| PREVIOUS CLOSE | 28.25 |
| VOLUME | 7524 |
| 52-Week high | 37.40 |
| 52-Week low | 19.50 |
| P/E | 14.23 |
| Mkt Cap.(Rs cr) | 23 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Concord Drugs Ltd. (CONCORDDRUGS) - Corporate Action
| ANNOUNCEMENT DATE | PURPOSE | AGM DATE | REMARKS |
| 13-08-2021 | AGM | 30-09-2021 | Concord Drugs Ltd has informed BSE regarding Outcome... |
| 04-12-2020 | AGM | 29-12-2020 | AGM 29/12/2020outcome of Board meeting(As Per BSE An... |
| 14-08-2019 | AGM | 30-09-2019 | Concord Drugs Ltd has informed BSE about Outcome of ... |
| 17-08-2018 | AGM | 29-09-2018 | Concord Drugs Ltd has informed BSE that the Register... |
| 28-08-2017 | AGM | 29-09-2017 | AGM 29/09/2017With reference to the subject cited th... |
| 17-08-2016 | AGM | 29-09-2016 | AGM 29.09.2016Concord Drugs Ltd has informed BSE reg... |
| 01-09-2015 | AGM | 30-09-2015 | AGM 30.09.2015Concord Drugs Ltd has informed BSE tha... |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
